High soluble CD30 levels and associated anti-HLA antibodies in patients with failed renal allografts
Yazar
Caliskan, Bahar
Oguz, Fatma S.
Bakkaloglu, Huseyin
Turkmen, Aydin
Sever, Mehmet S.
Karahan, Gonca E.
Caliskan, Yasar
Ozdilli, Kursat
Kekik, Cigdem
Üst veri
Tüm öğe kaydını gösterÖzet
Introduction: Serum soluble CD30 (sCD30), a 120-kD glycoprotein that belongs to the tumor necrosis factor receptor family, has been suggested as a marker of rejection in kidney transplant patients. The aim of this study was to evaluate the relationship between sCD30 levels and anti-HLA antibodies, and to compare sCD30 levels in patients undergoing hemodialysis (HD) with and without failed renal allografts and transplant recipients with functioning grafts.
Koleksiyonlar
- Makale [92796]